Prevalence of HIV and syphilis among Turkish blood donors
To the Editor: Screening of blood is now mandatory for many diseases and is undertaken routinely in blood banks. Many studies have been done on human immunodeficiency vir r rus (HIV) and syphilis, separately, but knowledge about the interrelar r tionship between these transfusion transmitted diseases is limited. 1, 2 This study was undertaken to assess the correlation between positivity for HIV infection and syphilis among blood donors of Eskisehir. Donors who applied to our blood center in a 10ryear period (1998r2007) were retrospectively evaluated. No pror r fessional or honorary donation was included.
Serum samples were screened for antirHIV by ELISA (microparr r ticle enzyme immunoassay, Axym, Abbott Corp., IL, USA) and for syphilis by the Veneral Disease Research Laboratory (VDRL) test (nontreponemal test, immunotrep Omega Diagnostic, Scotland, UK). Samples were not screened for VDRL. Of the total of 19 630 individuals, 6850 (34%) were fer r males and 12 780 (66%) were males. VDRL positivity was found in 33 donors (0.168%) and antirHIV was positive in 3 cases (0.015%) ( Table  1) . When the VDRL test was posir r tive, a confirmatory treponemal test was done. AntirHIV positivity was also confirmed by the western blot test. For the statistical analyses, chir square and the Fisher exact test were used.
The prevalence of VDRL reacr r tivity varied from 0.03% to 0.3% in blood donors in different regions of Turkey.
3 VDRL reactivty increased from 0.1% in first period to 0.3% in the second period (P=.001). This seems to be an alarming signal in the local blood banks for the probr r able increase in syphilis and further diagnostic tests should be applied in these cases. According to the rer r sults reported from other regions of Turkey, antirHIV positivity rates ranged between 0% and 0.66%. 4 AntirHIV positivity was not found in the first period , but in the second period it was 0.03% (P=.105). Two donors with positive HIV serology (66.6%) were also positive for VDRL (P≤.001). The problem of safe blood has become an issue worldwide; there is no available method to reduce the infection risk from transfusion to zero. Thus, it appears to be essential to carefully select appropriate donors and to avoid unnecessary transfur r sion. In conclusion, blood donors in our region show lower seropositivity rates, although there seems to be a regular increase in the rates of antir HIV and syphilis. Thus, taking into consideration the rising prevalence of these infections, a routine screenr r ing of all the donated blood products for antirHIV and syphilis should be done, which will assist blood transr r fusion services in improving transfur r sion safety. both written originally in Persian.
Concerning the name, "Iran" was firmly put on the map over a thour r sand years ago by Ferdowsi, one of the greatest world poets, who crer r ated the masterpiece of Shahnameh where he mentioned the name of this country as "Iran" several times. Accidentally, Ferdowsi and PourerSina were contemporary. To convince Dr. Haddad, I quote Professor Majeed that "Arab scholr r ars translated philosophical and scientific works from Greek, Syriac, Pahlavi (the scholarly language of prerIslamic Iran) and Sanskrit into Arabic." 5 Back to the anatomy charts presented by Dr. Haddad, I want to emphasize that the two plates presented so far, are from a treatise written by Mansouri Shirazi. The number of these charts as menr r tioned in his book is limited to five. 8 The language of that book is Persian and the work has not yet been transr r lated to any other languages. 
Dr. Behrooz Broumand
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In response to the query of Professor Doctor Behrooz Broumand: "Where was Avicenna and Rhazes from?" I say: the first was born in the village of Afshana near Bukhara and the second was born in Raÿÿ in the province of Fars. Bukhara is in presentrday Uzbekistan, hence a few people maintain that Avicenna was Uzbekÿ and others think he is Russian! In order to economize space and time, and to cut short a polemic that seems to have no end, I refer the reader to a few of my pubr r lished works on Avicenna and on Rhazes. If we return to our main topic, the anatomy charts, of which there are over seventy scattered around the world in various manuscripts. I have been trying to decipher their enigma for over 20 years without much success. We are planning, and hopefully we can achieve the main purpose of our plan; which is to publish most of these charts so that they reside in the public domain at the disposal of researchers who may be interested to decipher some of the following secrets: who is the author of these charts? What is the relation of one set to the other? What is their medical and historical importance, if any?
It is my hope that other readers might help in the solution of this puzzle rather than bring a dim set of chauvinistic glasses and sidestep the worthy endeavor. 
Male hypogonadism in a patient with Cogan synd d drome
To the Editor: Cogan syndrome is a rare, rheumatic disease characr r terized by inflammation of the ears and eyes that may also be associr r ated with vasculitis in other areas of the body. 1 Lunardi and colleagues advanced identification of the eye, inner ear, nervous system and enr r dothelium autoantigens of Cogan syndrome with their finding that the isolated 12rresidue Cogan peptide is homologous to four autoantigens: laminin, connexin 26, the collagen diseaserassociated Ssa/Ro, and the receptorrlike phosphatase DEPr 1/CD148, and one viral protein. The condition can lead to visual difr r ficulty, hearing loss and dizziness. It is fatal in less than 10% of patients. Mild disease may be treated with antirinflammatory medications, inr r cluding steroids and nonsteroidal antirinflammatory drugs.
The agerrelated decrease in testosterone and potential hypor r gonadism may result in decreased libido and erectile dysfunction, loss of muscle mass and strength, weight gain, and declining cognitive funcr r tion.
3r5 Men on longrterm corticor r steroid therapy often have low tesr r tosterone levels. 6 Androgen receptor levels are regulated by androgens, other steroids and nonrsteroidal hormones.
7 Therefore, we thought it would be interesting to highlight a case of male hypogonadism in a par r tient with Cogan syndrome.
A 47ryearrold male with increasr r ing loss of sexual drive, general lack of enthusiasm, and frequent exr r haustion presented to our departr r ment because of loss of libido and erectile dysfunction for one year. He was divorced without children. Four years previously, a diagnosis of Cogan syndrome was made based on a bilateral progressive hearing loss, tinnitus and ataxia, as well as a bilateral interstitial keratitis folr r lowing a viral infection of the upper airways. He had previously been treated with methylprednisolone for approximately 4 years with a mainr r tenance dose of 4 mg daily. Physical examination revealed sparse secondr r ary hair, muscle atrophy, a normal prostate and testis with a volume of 8 mL on both sides. All baseline hematological, biochemical and adr r ditional hormone parameters where within normal values except for tor r tal cholesterol 9. A semen analysis showed azoosperr r mia. Chromosome analysis excluded abnormalities, so the karyotype was 46,XY. Testicular biopsy confirmed marked hyalinization and thickenr r ing of the basement membrane of the spermatic tubules. Color duplex sonography of the aorta and intraabr r dominal vessels excluded severe vasr r cular manifestations of Cogan synr r drome. Osteodensitometry revealed a normal bone density for age. Therapy with intramuscular injecr r tions of testosterone enanthate 250 mg was started every 3 weeks and atorvastatin 20 mg daily was addr r ed. At last review, lipids were well controlled. Corticosteroids have a catabolic effect, often intensified by the androgen deficiency. Contrary to the fact that longrterm therapy with corticosteroids can induce secr r ondary hypogonadism our patient developed primary hypogonadism. Testicular biopsy excluded vasculitis as an underlying pathological mechr r anism. Our case is a clear example of a rare systemic autoimmune disr r ease that requires a broad multidisr r ciplinary approach to optimize its treatment and improve the patient' s wellrbeing. 
Anovestibular fistula with imperforate anus ın two adults
To the Editor: Imperforate anus occurs in one of 2500 to 5000 live births. 1 It is reported that the majority of girls with imperfor r rate anus will have a fistula to the perineum, fourchette, or vestibule. 1 Anovestibular fistula (AVF) is the most common form of anor r rectal anomaly in female infants. 2 Treatment of these lesions can be by a variety of techniques includr r ing anal transposition, or posterior or anterior sagittal anorectoplasty in the neonatal period.
2r4 These procedures can be safely performed with or without a diverting colosr r tomy. To our knowledge, only two cases of AVF presenting in adultr r hood have been described in the literature. 5 Posterior and anterior sagittal anorectoplasty were perr r formed in these cases. 5 We report anal transposition for AVF for the first time in two adults.
An 18ryearrold female par r tient was referred to our institur r tion with the chief complaint of defecating from the vulvovaginal vestibule. The family recognized the abnormal place of defecation at birth, but no attempt was done for the management of this par r thology. There was also a history of intermittent constipation but no history suggestive of intestinal obstruction. However, the patient denied a history of frequent uror r genital infections. On physical exr r amination, the patient was found to have imperforate anus and AVF (Figure 1) . No additional urogyr r necologic abnormality was found on detailed physical examination. An abdominopelvic ultrasound did not reveal any abnormality of the urogenital system. Anal transr r position without colostomy was performed in the gynecologic por r sition under general anesthesia (Figure 2,3) . She had an uneventr r ful postoperative recovery and was discharged on the seventh postopr r erative day. She was well doing on the 33rmonth followrup without any complication. The Cleveland Clinic Incontinence Score (CCIS) was 5 (good continence). She had no complaints about her social life after marriage.
The second case was a 19ryearr old female patient referred to our institution with the complaint of defecating from a vulvovaginal vesr r tibule and constipation. Admission for treatment was due to the decir r sion of marriage. The medical hisr r tory and complaints of the patient were similar to the first case. On physical examination, she was dir r agnosed with an imperforate anus 5 We perr r formed anal transposition without colostomy in the treatment of both cases. Colostomy may not be necesr r sary in adult patients in the case of optimal fecal passage. Colostomy is a poorly tolerated procedure in adult patients compared with neonatal patients. For this reason, surgical interventions without colostomy is probably a better surgical option in adults with AVF. Single staged anal transposition without colostomy as a minor, safe operation may be the technique of choice for treatment of adults with imperforate anus and anovestibular fistula with satisfacr r tory continence and perineal cosr r mesis (Figure 4 ).
